<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>U.S. SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT PURSUANT TO SECTION
13 OR 15(d)</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF THE SECURITIES EXCHANGE ACT OF
1934</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event
reported): <B>March 7, 2012</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center"><B>NUTRA
PHARMA CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">(Exact
name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-align: center"><U>California</U></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-decoration: underline; text-align: center">000-32141</TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-decoration: underline; text-align: center">91-2021600</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-align: center">&nbsp; (State or jurisdiction of</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-align: center">(Commission</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-align: center">(I.R.S. Employer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-align: center">incorporation or organization)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-align: center">&nbsp;File Number)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; text-align: center">&nbsp;Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">2776 University Drive</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Coral Springs, Florida 33065</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">(Address of principal
executive offices) (Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">Registrant's telephone
number: 954-509-0911</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">------------------------------------------------------</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">(Former
name or former address, if changed since last report)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Nutra Pharma Corp. is referred to herein as &ldquo;we,&rdquo;
&ldquo;our,&rdquo; or &ldquo;us&rdquo;.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Section 1 &ndash; Registrant&rsquo;s Business and Operations
</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 5.02. Departure of Directors or Principal Officers;
Election of Directors; Appointment of Principal Officers</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B><I>Appointment of Bruno Sartori as our Chief Financial
Officer</I></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On March 7, 2012, our Board of Directors unanimously approved
of the appointment of Bruno Sartori as our Chief Financial Officer.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B><I>Biographical Information </I></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Mr. Sartori is 56 years of age. From August 2010
to March 6, 2012, Mr. Sartori acted as our full-time consultant regarding accounting matters. From April 1995 to November
2005 and from January 2008 to July 2010, Mr. Sartori operated his own accounting practice. From December 2005 to December
2007, Mr. Sartori was the Chief Financial Officer of Trend USA, Ltd and affiliates, a subsidiary of Trend Group, S.P.A, an
international manufacturer, seller and distributor of agglomerates, glass mosaics and tiles. Mr. Sartori has a total of 27
years of accounting experience and has been licensed as a Certified Public Accountant in Florida since October 1985. In May
1983, Mr. Sartori graduated from Florida Atlantic University with an accounting degree.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>No Arrangements or Understandings</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no arrangements or understandings pursuant to which
Mr. Sartori was appointed by our Board of Directors as our Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>No Family Relationships</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no family arrangements between Mr. Sartori and any
of our other officer or directors or any person or entity affiliated with us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>No Involvement in Certain Legal Proceedings. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Over the past 10 years, Mr. Sartori has not: (a) been involved
as a general partner or executive officer of any business, which has filed a bankruptcy petition; (b) been convicted in a criminal
proceeding or a named subject of a pending criminal proceeding; (c) been found a court, the Securities and Exchange Commission
or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law; (d) been the subject
of any order, judgment or degree, permanently or temporarily enjoining him from or otherwise limiting, the following activities:
(i) acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker,
leverage transaction, merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person
of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person,
director or employee of any investment company, bank savings and loan association or insurance company, or engaging in or continuing
any conduct or practice in connection with such activity; (ii) engaging in any type of business practice; or engaging in any activity
in connection with any violation of federal or state securities laws or federal commodities laws. Further, Mr. Sartori has never
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding relating
to an alleged violation of any federal or state securities or commodities law or regulation; or any law or regulation respecting
financial institutions or insurance companies, including, but not limited to, a temporary or permanent injunction, order of disgorgement
or restitution, civil money penalty or temporary or permanent cease and desist order, or removal or prohibition order; or any law
or regulation prohibiting mail or wire fraud or fraud in connection with any business entity.</P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 45.8pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B><U>SIGNATURES</U></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Registrant has duly caused this report to be signed on its
behalf by the</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Dated: March 9, 2012</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Nutra Pharma Corp.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><U>/s/ Rik J Deitsch</U></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">By: Rik J Deitsch, Chief Executive Officer/Director</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v305220_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 13000}]
{"company-data": {"conformed-name": "NUTRA PHARMA CORP", "cik": "0001119643", "assigned-sic": "2833", "irs-number": "912021600", "state-of-incorporation": "CA"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-32141", "film-number": "12678800"}, "business-address": {"street1": "2776 UNIVERSITY DRIVE", "city": "CORAL SPRINGS,", "state": "FL", "zip": "33065", "phone": "(954) 509-0911"}, "mail-address": {"street1": "2776 UNIVERSITY DRIVE", "city": "CORAL SPRINGS,", "state": "FL", "zip": "33065"}, "former-company": {"former-conformed-name": "CYBER VITAMIN COM", "date-changed": "20000717"}}
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION
13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF
1934
Date of Report (Date of earliest event
reported):
March 7, 2012
NUTRA
PHARMA CORP.
(Exact
name of registrant as specified in its charter)
California
000-32141
91-2021600
(State or jurisdiction of
(Commission
(I.R.S. Employer
incorporation or organization)
File Number)
Identification No.)
2776 University Drive
Coral Springs, Florida 33065
(Address of principal
executive offices) (Zip Code)
Registrant's telephone
number: 954-509-0911
------------------------------------------------------
(Former
name or former address, if changed since last report)
Nutra Pharma Corp. is referred to herein as "we,"
"our," or "us".
Section 1 – Registrant's Business and Operations
Item 5.02. Departure of Directors or Principal Officers;
Election of Directors; Appointment of Principal Officers
Appointment of Bruno Sartori as our Chief Financial
Officer
On March 7, 2012, our Board of Directors unanimously approved
of the appointment of Bruno Sartori as our Chief Financial Officer.
Biographical Information
Mr. Sartori is 56 years of age. From August 2010
to March 6, 2012, Mr. Sartori acted as our full-time consultant regarding accounting matters. From April 1995 to November
2005 and from January 2008 to July 2010, Mr. Sartori operated his own accounting practice. From December 2005 to December
2007, Mr. Sartori was the Chief Financial Officer of Trend USA, Ltd and affiliates, a subsidiary of Trend Group, S.P.A, an
international manufacturer, seller and distributor of agglomerates, glass mosaics and tiles. Mr. Sartori has a total of 27
years of accounting experience and has been licensed as a Certified Public Accountant in Florida since October 1985. In May
1983, Mr. Sartori graduated from Florida Atlantic University with an accounting degree.
No Arrangements or Understandings
There are no arrangements or understandings pursuant to which
Mr. Sartori was appointed by our Board of Directors as our Chief Financial Officer.
No Family Relationships
There are no family arrangements between Mr. Sartori and any
of our other officer or directors or any person or entity affiliated with us.
No Involvement in Certain Legal Proceedings.
Over the past 10 years, Mr. Sartori has not: (a) been involved
as a general partner or executive officer of any business, which has filed a bankruptcy petition; (b) been convicted in a criminal
proceeding or a named subject of a pending criminal proceeding; (c) been found a court, the Securities and Exchange Commission
or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law; (d) been the subject
of any order, judgment or degree, permanently or temporarily enjoining him from or otherwise limiting, the following activities:
(i) acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker,
leverage transaction, merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person
of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person,
director or employee of any investment company, bank savings and loan association or insurance company, or engaging in or continuing
any conduct or practice in connection with such activity; (ii) engaging in any type of business practice; or engaging in any activity
in connection with any violation of federal or state securities laws or federal commodities laws. Further, Mr. Sartori has never
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding relating
to an alleged violation of any federal or state securities or commodities law or regulation; or any law or regulation respecting
financial institutions or insurance companies, including, but not limited to, a temporary or permanent injunction, order of disgorgement
or restitution, civil money penalty or temporary or permanent cease and desist order, or removal or prohibition order; or any law
or regulation prohibiting mail or wire fraud or fraud in connection with any business entity.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the
Registrant has duly caused this report to be signed on its
behalf by the
undersigned hereunto duly authorized.
Dated: March 9, 2012
Nutra Pharma Corp.
/s/ Rik J Deitsch
By: Rik J Deitsch, Chief Executive Officer/Director